Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMC 124289)

Published in Proc Natl Acad Sci U S A on May 28, 2002

Authors

Julio C Delgado1, Eunice Y Tsai, Sok Thim, Andres Baena, Vassiliki A Boussiotis, Jean-Marc Reynes, Sun Sath, Pierre Grosjean, Edmond J Yunis, Anne E Goldfeld

Author Affiliations

1: Center for Blood Research, Harvard Medical School, Boston, MA 02115, USA.

Articles citing this

IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest (2004) 3.69

Identification of the yeast gene encoding the tRNA m1G methyltransferase responsible for modification at position 9. RNA (2003) 2.23

Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis (2005) 1.87

Tuberculosis skin testing, anergy and protein malnutrition in Peru. Int J Tuberc Lung Dis (2005) 1.48

Vgamma2Vdelta2+ T cells and anti-microbial immune responses. Microbes Infect (2003) 1.18

T-cell immunophenotyping distinguishes active from latent tuberculosis. J Infect Dis (2013) 1.18

Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Dev Immunol (2012) 1.16

Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens. Infect Immun (2011) 1.16

Peripheral blood gamma interferon release assays predict lung responses and Mycobacterium tuberculosis disease outcome in mice. Clin Vaccine Immunol (2008) 1.11

IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB. PLoS One (2009) 1.09

The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10. Infect Immun (2003) 1.07

Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection. J Clin Microbiol (2004) 1.05

Electroacupuncture and moxibustion promote neutrophil apoptosis and improve ulcerative colitis in rats. Dig Dis Sci (2007) 1.04

Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection. Am J Respir Crit Care Med (2010) 1.03

The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life. PLoS One (2010) 1.00

Immune regulation of gammadelta T cell responses in mycobacterial infections. Clin Immunol (2005) 0.99

Gene expression profiles of bronchoalveolar cells in pulmonary TB. Tuberculosis (Edinb) (2007) 0.98

Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination. Front Immunol (2015) 0.89

Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis. Mol Immunol (2009) 0.87

Role of 4-1BB receptor in the control played by CD8(+) T cells on IFN-gamma production by Mycobacterium tuberculosis antigen-specific CD4(+) T Cells. PLoS One (2010) 0.83

Diversity in mechanism and function of tRNA methyltransferases. RNA Biol (2015) 0.78

TB or not TB? Difficulties in the diagnosis of tuberculosis in HIV-negative immigrants to Germany. Eur J Med Res (2011) 0.78

Tuberculin skin test result and risk of death among persons with active TB. PLoS One (2013) 0.78

Decreased expression of T-cell costimulatory molecule CD28 on CD4 and CD8 T cells of mexican patients with pulmonary tuberculosis. Tuberc Res Treat (2010) 0.75

Use of pulmonary interferon {gamma} responses to mycobacterial antigen to distinguish sarcoid associated optic neuropathy from tuberculosis. Br J Ophthalmol (2006) 0.75

Isolated cerebellar tuberculoma mimicking posterior cranial fossa tumour. BMJ Case Rep (2013) 0.75

Aberrant plasma IL-7 and soluble IL-7 receptor levels indicate impaired T-cell response to IL-7 in human tuberculosis. PLoS Pathog (2017) 0.75

Articles cited by this

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82

Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med (2000) 13.69

Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med (2000) 10.50

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med (1999) 8.80

Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA (1992) 3.81

Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell (1994) 3.71

Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med (1990) 3.38

IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest (2000) 3.19

Editorial: Measurement of delayed skin-test responses. N Engl J Med (1975) 2.99

Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science (1997) 2.33

Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals. Medicine (Baltimore) (1984) 2.28

Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med (1986) 2.09

Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med (1971) 1.63

Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol (1992) 1.59

Association of an HLA-DQ allele with clinical tuberculosis. JAMA (1998) 1.58

An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci U S A (1997) 1.55

Anergy in active pulmonary tuberculosis. A comparison between positive and negative reactors and an evaluation of 5 TU and 250 TU skin test doses. Chest (1980) 1.54

[Results in pulmonary tuberculosis patients under various treatment program conditions]. Bull Int Union Tuberc (1978) 1.51

Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J Infect Dis (1989) 1.48

Reliability of anergy skin testing in persons with HIV infection. The pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med (1996) 1.48

Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products. Tuberculosis (Edinb) (2001) 1.16

Human leukocyte antigen-associated susceptibility to pulmonary tuberculosis: molecular analysis of class II alleles by DNA amplification and oligonucleotide hybridization in Mexican patients. Chest (1999) 1.07

The case against anergy testing as a routine adjunct to tuberculin skin testing. JAMA (2000) 1.02

Evaluation of the clinical usefulness of mycobacterial skin test antigens in adults with pulmonary mycobacterioses. Am Rev Respir Dis (1992) 0.95

Polymerase chain reaction--based sequence-specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis: relevance to chemotherapy and disease severity. J Infect Dis (1996) 0.90

Tuberculosis in patients with various HLA phenotypes. Tubercle (1990) 0.88

Treatment and prevention of tuberculosis in HIV infection. AIDS (1993) 0.79

Selection of skin test antigens to evaluate PPD anergy. J Fam Pract (1995) 0.79

Articles by these authors

Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med (2006) 11.14

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med (2011) 7.13

Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3. Curr Biol (2006) 3.81

IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest (2004) 3.69

RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion. Dev Cell (2004) 3.27

Lamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics. Dev Cell (2004) 2.96

Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J Exp Med (2004) 2.32

Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation. Sci Signal (2012) 2.24

The origin and phylogeography of dog rabies virus. J Gen Virol (2008) 2.23

Rift Valley fever during rainy seasons, Madagascar, 2008 and 2009. Emerg Infect Dis (2010) 2.22

Henipavirus and Tioman virus antibodies in pteropodid bats, Madagascar. Emerg Infect Dis (2007) 2.05

Outbreak of dengue and Chikungunya fevers, Toamasina, Madagascar, 2006. Emerg Infect Dis (2008) 2.02

Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation. Immunity (2009) 2.00

Sustained transmission of dengue virus type 1 in the Pacific due to repeated introductions of different Asian strains. Virology (2004) 1.94

Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin alphaIIbbeta3. J Cell Biol (2008) 1.93

A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance. Nat Immunol (2006) 1.89

Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis. Blood (2010) 1.88

Prediction, assessment of the Rift Valley fever activity in East and Southern Africa 2006-2008 and possible vector control strategies. Am J Trop Med Hyg (2010) 1.81

Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Invest (2011) 1.80

CTLA-4 regulates cell cycle progression during a primary immune response. Eur J Immunol (2002) 1.78

Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis (2002) 1.74

The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells. Proc Natl Acad Sci U S A (2008) 1.61

HIV, STIs, and sexual behaviors among men who have sex with men in Phnom Penh, Cambodia. AIDS Educ Prev (2004) 1.59

CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. J Immunol (2002) 1.58

CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood (2005) 1.53

T cell anergy and costimulation. Immunol Rev (2003) 1.52

A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis (2008) 1.45

Regulation of tumor necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300. Mol Cell Biol (2003) 1.42

Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. J Antimicrob Chemother (2006) 1.38

Genetic evidence for Rift Valley fever outbreaks in Madagascar resulting from virus introductions from the East African mainland rather than enzootic maintenance. J Virol (2011) 1.38

Viral etiology of influenza-like illnesses in Antananarivo, Madagascar, July 2008 to June 2009. PLoS One (2011) 1.38

Prevalence of Rift Valley fever infection in ruminants in Madagascar after the 2008 outbreak. Vector Borne Zoonotic Dis (2011) 1.37

Identification of a macrophage-specific chromatin signature in the IL-10 locus. J Immunol (2005) 1.37

Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. Mol Immunol (2008) 1.36

Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J Infect Dis (2008) 1.36

Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol (2008) 1.32

Transcriptional control of the TNF gene. Curr Dir Autoimmun (2010) 1.32

The haplotype structure of the human major histocompatibility complex. Hum Immunol (2006) 1.29

The role of wild mammals in the maintenance of Rift Valley fever virus. J Wildl Dis (2012) 1.29

T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev (2015) 1.26

Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials. J Infect Dis (2007) 1.24

High frequency and diversity of species C enteroviruses in Cameroon and neighboring countries. J Clin Microbiol (2012) 1.24

Etiology of encephalitis syndrome among hospitalized children and adults in Takeo, Cambodia, 1999-2000. Am J Trop Med Hyg (2002) 1.22

Disputed maternity leading to identification of tetragametic chimerism. N Engl J Med (2002) 1.21

A community-based tuberculosis program in Cambodia. JAMA (2004) 1.21

Inducer-specific enhanceosome formation controls tumor necrosis factor alpha gene expression in T lymphocytes. Mol Cell Biol (2002) 1.20

Activation-dependent intrachromosomal interactions formed by the TNF gene promoter and two distal enhancers. Proc Natl Acad Sci U S A (2007) 1.18

Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin. J Immunol (2009) 1.18

IL-1β-mediated signals preferentially drive conversion of regulatory T cells but not conventional T cells into IL-17-producing cells. J Immunol (2010) 1.17

Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Dev Immunol (2012) 1.16

Pandemic A/H1N1/2009 influenza virus in swine, Cameroon, 2010. Vet Microbiol (2011) 1.16

Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial. AIDS (2013) 1.16

Intrinsic and extrinsic regulation of T lymphocyte quiescence. Leuk Lymphoma (2004) 1.16

Interleukin-7 in T-cell acute lymphoblastic leukemia: an extrinsic factor supporting leukemogenesis? Leuk Lymphoma (2005) 1.13

Norovirus infection in children with acute gastroenteritis, Madagascar, 2004-2005. Emerg Infect Dis (2007) 1.12

PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A. Cell Cycle (2012) 1.12

IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL. Blood (2003) 1.10

More accurate insight into the incidence of human rabies in developing countries through validated laboratory techniques. PLoS Negl Trop Dis (2010) 1.07

Rap1-interacting adapter molecule (RIAM) associates with the plasma membrane via a proximity detector. J Cell Biol (2012) 1.06

NFAT5 binds to the TNF promoter distinctly from NFATp, c, 3 and 4, and activates TNF transcription during hypertonic stress alone. Nucleic Acids Res (2005) 1.06

Common and diverse features of cocirculating type 2 and 3 recombinant vaccine-derived polioviruses isolated from patients with poliomyelitis and healthy children. J Infect Dis (2012) 1.05

Partial molecular characterization of alphaherpesviruses isolated from tropical bats. J Gen Virol (2009) 1.05

Post-induction, stimulus-specific regulation of tumor necrosis factor mRNA expression. J Biol Chem (2007) 1.05

Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report. Immunol Res (2009) 1.02

Photoeradication of Helicobacter pylori using 5-aminolevulinic acid: preliminary human studies. Lasers Surg Med (2002) 1.01

Rap1-GTP-interacting adaptor molecule (RIAM) protein controls invasion and growth of melanoma cells. J Biol Chem (2011) 1.00

PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2. Mol Cell Biol (2013) 0.99

Detection, isolation, and genetic characterization of Rift Valley fever virus from Anopheles (Anopheles) coustani, Anopheles (Anopheles) squamosus, and Culex (Culex) antennatus of the Haute Matsiatra region, Madagascar. Vector Borne Zoonotic Dis (2010) 0.99

cAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression. Blood (2002) 0.99

NFAT5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site. PLoS Pathog (2006) 0.99

Aspartic acid homozygosity at codon 57 of HLA-DQ beta is associated with susceptibility to pulmonary tuberculosis in Cambodia. J Immunol (2006) 0.98

In vivo autofluorescence imaging of early cancers in the human tracheobronchial tree with a spectrally optimized system. J Biomed Opt (2003) 0.97

Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs. J Immunol (2008) 0.96

HLA class I and class II conserved extended haplotypes and their fragments or blocks in Mexicans: implications for the study of genetic diversity in admixed populations. PLoS One (2013) 0.96

CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectors. Biol Blood Marrow Transplant (2008) 0.96

Common gamma chain-signaling cytokines promote proliferation of T-cell acute lymphoblastic leukemia. Haematologica (2004) 0.96

Transactivator of transcription from HIV type 1 subtype E selectively inhibits TNF gene expression via interference with chromatin remodeling of the TNF locus. J Immunol (2006) 0.94

HIV-1 replication is differentially regulated by distinct clinical strains of Mycobacterium tuberculosis. PLoS One (2009) 0.94

Epigenetic control of cytokine gene expression: regulation of the TNF/LT locus and T helper cell differentiation. Adv Immunol (2013) 0.94

Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses. Blood (2002) 0.93

The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer. Clin Immunol (2013) 0.93

Arc of a vicious circle: pathways activated by Mycobacterium tuberculosis that target the HIV-1 long terminal repeat. Am J Respir Cell Mol Biol (2011) 0.93

Absence of Rift Valley fever virus in wild small mammals, Madagascar. Emerg Infect Dis (2013) 0.93

Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo. Biol Blood Marrow Transplant (2007) 0.92

Variation over space and time of Aedes aegypti in Phnom Penh (Cambodia): genetic structure and oral susceptibility to a dengue virus. Genet Res (2003) 0.92

Primate TNF promoters reveal markers of phylogeny and evolution of innate immunity. PLoS One (2007) 0.92

Tob, a member of the APRO family, regulates immunological quiescence and tumor suppression. Cell Cycle (2009) 0.92

Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E. BMC Genet (2007) 0.91